Loading…
Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer
Abstract Context The Edmonton Symptom Assessment System (ESAS) is a brief, widely adopted, multidimensional questionnaire to evaluate patient-reported symptoms. Objectives To develop a Korean version of the ESAS (K-ESAS) and to perform a psychometric analysis in Korean patients with advanced cancer....
Saved in:
Published in: | Journal of pain and symptom management 2013-12, Vol.46 (6), p.947-956 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3 |
container_end_page | 956 |
container_issue | 6 |
container_start_page | 947 |
container_title | Journal of pain and symptom management |
container_volume | 46 |
creator | Kwon, Jung Hye, MD, PhD Nam, Seung-Hyun, MD Koh, Sujin, MD, PhD Hong, Young Seon, MD, PhD Lee, Kyung Hee, MD, PhD Shin, Sang-Won, MD, PhD Hui, David, MD, MSc, FRCPC Park, Kyun Woo, MD Yoon, So Young, MD, PhD Won, Ji Yun, RN Chisholm, Gary, MS Bruera, Eduardo, MD |
description | Abstract Context The Edmonton Symptom Assessment System (ESAS) is a brief, widely adopted, multidimensional questionnaire to evaluate patient-reported symptoms. Objectives To develop a Korean version of the ESAS (K-ESAS) and to perform a psychometric analysis in Korean patients with advanced cancer. Methods We tested the K-ESAS in two pilot studies with 15 patients each. We assessed internal consistency, test-retest reliability, and concurrent validity in 163 Korean patients, who completed the K-ESAS along with the Korean versions of the M. D. Anderson Symptom Inventory (K-MDASI) and the Hospital Anxiety and Depression Scale (K-HADS) twice. A total of 38 patients completed the questionnaires again seven days later to assess responsiveness. Results The K-ESAS scores had good internal consistency, with a Cronbach's alpha coefficient of 0.88, indicating that no questions had undue influence on the score. Pearson correlation coefficients for K-ESAS symptom scores between baseline and after two to four hours ranged from 0.72 (95% CI 0.64–0.79) to 0.87 (95% CI 0.82–0.90), indicating strong test-retest reliability. For concurrent validity, Pearson correlation coefficients between K-ESAS symptom scores and corresponding K-MDASI symptom scores ranged from 0.70 (95% CI 0.62–0.77) to 0.83 (95% CI 0.77–0.87), indicating good concurrent validity. For the K-HADS, concurrent validity was good for anxiety ( r = 0.73, 95% CI 0.65–0.79) but moderate for depression ( r = 0.4, 95% CI 0.26–0.52). For responsiveness, changes in K-ESAS scores after seven days were moderately correlated with changes in K-MDASI scores but weakly correlated with changes in K-HADS scores. Conclusion The K-ESAS is a valid and reliable tool for measuring multidimensional symptoms in Korean patients with cancer. |
doi_str_mv | 10.1016/j.jpainsymman.2013.01.012 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1550986325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0885392413001875</els_id><sourcerecordid>1464891632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3</originalsourceid><addsrcrecordid>eNqNkluLEzEUgIMobl39CzI-CPsyNZdJmrwIS1kvuKBQL48hTU7ZjJOkJqnQf2-G1gu-KBwISb5zTvhyEHpG8JJgIl6My3FvfCzHEExcUkzYEpMW9B5aELliveCE3UcLLCXvmaLDBXpUyogx5kywh-iCMkElJ2KBNp_N5J2pPsUu7bp6B92NCynWtt8cw76m0F2XAqUEiLUdlQqh87F7lzKY2H1oqe2idF98vevWJlrIj9GDnZkKPDmvl-jTq5uP6zf97fvXb9fXt73lg6j9wBh30jihtkRyxhh1VnCpKAcmyEpiA9yC40oCNcLhgQ5uBaAGwjBQvmWX6OpUd5_TtwOUqoMvFqbJREiHognnWEnBKP83OohBKtLYhqoTanMqJcNO77MPJh81wXrWr0f9h34969eYtJhzn57bHLYB3K_Mn74b8PwMmGLNtMtNmC-_OYkZVVg1bn3ioPn77iHrYpvnpsNnsFW75P_rOS__qmInH31r_BWOUMZ0yLF9kCa6UI31Zp6XeVyaYNzmiLMfbg689A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1464891632</pqid></control><display><type>article</type><title>Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>ScienceDirect Freedom Collection</source><creator>Kwon, Jung Hye, MD, PhD ; Nam, Seung-Hyun, MD ; Koh, Sujin, MD, PhD ; Hong, Young Seon, MD, PhD ; Lee, Kyung Hee, MD, PhD ; Shin, Sang-Won, MD, PhD ; Hui, David, MD, MSc, FRCPC ; Park, Kyun Woo, MD ; Yoon, So Young, MD, PhD ; Won, Ji Yun, RN ; Chisholm, Gary, MS ; Bruera, Eduardo, MD</creator><creatorcontrib>Kwon, Jung Hye, MD, PhD ; Nam, Seung-Hyun, MD ; Koh, Sujin, MD, PhD ; Hong, Young Seon, MD, PhD ; Lee, Kyung Hee, MD, PhD ; Shin, Sang-Won, MD, PhD ; Hui, David, MD, MSc, FRCPC ; Park, Kyun Woo, MD ; Yoon, So Young, MD, PhD ; Won, Ji Yun, RN ; Chisholm, Gary, MS ; Bruera, Eduardo, MD</creatorcontrib><description>Abstract Context The Edmonton Symptom Assessment System (ESAS) is a brief, widely adopted, multidimensional questionnaire to evaluate patient-reported symptoms. Objectives To develop a Korean version of the ESAS (K-ESAS) and to perform a psychometric analysis in Korean patients with advanced cancer. Methods We tested the K-ESAS in two pilot studies with 15 patients each. We assessed internal consistency, test-retest reliability, and concurrent validity in 163 Korean patients, who completed the K-ESAS along with the Korean versions of the M. D. Anderson Symptom Inventory (K-MDASI) and the Hospital Anxiety and Depression Scale (K-HADS) twice. A total of 38 patients completed the questionnaires again seven days later to assess responsiveness. Results The K-ESAS scores had good internal consistency, with a Cronbach's alpha coefficient of 0.88, indicating that no questions had undue influence on the score. Pearson correlation coefficients for K-ESAS symptom scores between baseline and after two to four hours ranged from 0.72 (95% CI 0.64–0.79) to 0.87 (95% CI 0.82–0.90), indicating strong test-retest reliability. For concurrent validity, Pearson correlation coefficients between K-ESAS symptom scores and corresponding K-MDASI symptom scores ranged from 0.70 (95% CI 0.62–0.77) to 0.83 (95% CI 0.77–0.87), indicating good concurrent validity. For the K-HADS, concurrent validity was good for anxiety ( r = 0.73, 95% CI 0.65–0.79) but moderate for depression ( r = 0.4, 95% CI 0.26–0.52). For responsiveness, changes in K-ESAS scores after seven days were moderately correlated with changes in K-MDASI scores but weakly correlated with changes in K-HADS scores. Conclusion The K-ESAS is a valid and reliable tool for measuring multidimensional symptoms in Korean patients with cancer.</description><identifier>ISSN: 0885-3924</identifier><identifier>EISSN: 1873-6513</identifier><identifier>DOI: 10.1016/j.jpainsymman.2013.01.012</identifier><identifier>PMID: 23628516</identifier><identifier>CODEN: JSPME2</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Advanced cancer ; Aged ; Anesthesia & Perioperative Care ; Anxiety-Depression ; Biological and medical sciences ; Cancer ; Correlation coefficients ; Edmonton Symptom Assessment System ; ESAS ; Female ; Humans ; Korea ; Male ; Medical sciences ; Middle Aged ; Multiple tumors. Solid tumors. Tumors in childhood (general aspects) ; Neoplasms - diagnosis ; Neoplasms - epidemiology ; Neoplasms - psychology ; Pain Medicine ; Pharmacology. Drug treatments ; Prevalence ; Psychometrics - methods ; Psychometrics - statistics & numerical data ; Quality of Life ; Reproducibility of Results ; Republic of Korea - epidemiology ; Responsiveness ; Sensitivity and Specificity ; Surveys and Questionnaires ; Symptom Assessment - methods ; Symptom Assessment - statistics & numerical data ; Symptoms ; Test-Retest reliability ; Tumors</subject><ispartof>Journal of pain and symptom management, 2013-12, Vol.46 (6), p.947-956</ispartof><rights>U.S. Cancer Pain Relief Committee</rights><rights>2013 U.S. Cancer Pain Relief Committee</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3</citedby><cites>FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,31000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28032909$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23628516$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kwon, Jung Hye, MD, PhD</creatorcontrib><creatorcontrib>Nam, Seung-Hyun, MD</creatorcontrib><creatorcontrib>Koh, Sujin, MD, PhD</creatorcontrib><creatorcontrib>Hong, Young Seon, MD, PhD</creatorcontrib><creatorcontrib>Lee, Kyung Hee, MD, PhD</creatorcontrib><creatorcontrib>Shin, Sang-Won, MD, PhD</creatorcontrib><creatorcontrib>Hui, David, MD, MSc, FRCPC</creatorcontrib><creatorcontrib>Park, Kyun Woo, MD</creatorcontrib><creatorcontrib>Yoon, So Young, MD, PhD</creatorcontrib><creatorcontrib>Won, Ji Yun, RN</creatorcontrib><creatorcontrib>Chisholm, Gary, MS</creatorcontrib><creatorcontrib>Bruera, Eduardo, MD</creatorcontrib><title>Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer</title><title>Journal of pain and symptom management</title><addtitle>J Pain Symptom Manage</addtitle><description>Abstract Context The Edmonton Symptom Assessment System (ESAS) is a brief, widely adopted, multidimensional questionnaire to evaluate patient-reported symptoms. Objectives To develop a Korean version of the ESAS (K-ESAS) and to perform a psychometric analysis in Korean patients with advanced cancer. Methods We tested the K-ESAS in two pilot studies with 15 patients each. We assessed internal consistency, test-retest reliability, and concurrent validity in 163 Korean patients, who completed the K-ESAS along with the Korean versions of the M. D. Anderson Symptom Inventory (K-MDASI) and the Hospital Anxiety and Depression Scale (K-HADS) twice. A total of 38 patients completed the questionnaires again seven days later to assess responsiveness. Results The K-ESAS scores had good internal consistency, with a Cronbach's alpha coefficient of 0.88, indicating that no questions had undue influence on the score. Pearson correlation coefficients for K-ESAS symptom scores between baseline and after two to four hours ranged from 0.72 (95% CI 0.64–0.79) to 0.87 (95% CI 0.82–0.90), indicating strong test-retest reliability. For concurrent validity, Pearson correlation coefficients between K-ESAS symptom scores and corresponding K-MDASI symptom scores ranged from 0.70 (95% CI 0.62–0.77) to 0.83 (95% CI 0.77–0.87), indicating good concurrent validity. For the K-HADS, concurrent validity was good for anxiety ( r = 0.73, 95% CI 0.65–0.79) but moderate for depression ( r = 0.4, 95% CI 0.26–0.52). For responsiveness, changes in K-ESAS scores after seven days were moderately correlated with changes in K-MDASI scores but weakly correlated with changes in K-HADS scores. Conclusion The K-ESAS is a valid and reliable tool for measuring multidimensional symptoms in Korean patients with cancer.</description><subject>Advanced cancer</subject><subject>Aged</subject><subject>Anesthesia & Perioperative Care</subject><subject>Anxiety-Depression</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Correlation coefficients</subject><subject>Edmonton Symptom Assessment System</subject><subject>ESAS</subject><subject>Female</subject><subject>Humans</subject><subject>Korea</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - psychology</subject><subject>Pain Medicine</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevalence</subject><subject>Psychometrics - methods</subject><subject>Psychometrics - statistics & numerical data</subject><subject>Quality of Life</subject><subject>Reproducibility of Results</subject><subject>Republic of Korea - epidemiology</subject><subject>Responsiveness</subject><subject>Sensitivity and Specificity</subject><subject>Surveys and Questionnaires</subject><subject>Symptom Assessment - methods</subject><subject>Symptom Assessment - statistics & numerical data</subject><subject>Symptoms</subject><subject>Test-Retest reliability</subject><subject>Tumors</subject><issn>0885-3924</issn><issn>1873-6513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNkluLEzEUgIMobl39CzI-CPsyNZdJmrwIS1kvuKBQL48hTU7ZjJOkJqnQf2-G1gu-KBwISb5zTvhyEHpG8JJgIl6My3FvfCzHEExcUkzYEpMW9B5aELliveCE3UcLLCXvmaLDBXpUyogx5kywh-iCMkElJ2KBNp_N5J2pPsUu7bp6B92NCynWtt8cw76m0F2XAqUEiLUdlQqh87F7lzKY2H1oqe2idF98vevWJlrIj9GDnZkKPDmvl-jTq5uP6zf97fvXb9fXt73lg6j9wBh30jihtkRyxhh1VnCpKAcmyEpiA9yC40oCNcLhgQ5uBaAGwjBQvmWX6OpUd5_TtwOUqoMvFqbJREiHognnWEnBKP83OohBKtLYhqoTanMqJcNO77MPJh81wXrWr0f9h34969eYtJhzn57bHLYB3K_Mn74b8PwMmGLNtMtNmC-_OYkZVVg1bn3ioPn77iHrYpvnpsNnsFW75P_rOS__qmInH31r_BWOUMZ0yLF9kCa6UI31Zp6XeVyaYNzmiLMfbg689A</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Kwon, Jung Hye, MD, PhD</creator><creator>Nam, Seung-Hyun, MD</creator><creator>Koh, Sujin, MD, PhD</creator><creator>Hong, Young Seon, MD, PhD</creator><creator>Lee, Kyung Hee, MD, PhD</creator><creator>Shin, Sang-Won, MD, PhD</creator><creator>Hui, David, MD, MSc, FRCPC</creator><creator>Park, Kyun Woo, MD</creator><creator>Yoon, So Young, MD, PhD</creator><creator>Won, Ji Yun, RN</creator><creator>Chisholm, Gary, MS</creator><creator>Bruera, Eduardo, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QJ</scope></search><sort><creationdate>20131201</creationdate><title>Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer</title><author>Kwon, Jung Hye, MD, PhD ; Nam, Seung-Hyun, MD ; Koh, Sujin, MD, PhD ; Hong, Young Seon, MD, PhD ; Lee, Kyung Hee, MD, PhD ; Shin, Sang-Won, MD, PhD ; Hui, David, MD, MSc, FRCPC ; Park, Kyun Woo, MD ; Yoon, So Young, MD, PhD ; Won, Ji Yun, RN ; Chisholm, Gary, MS ; Bruera, Eduardo, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Advanced cancer</topic><topic>Aged</topic><topic>Anesthesia & Perioperative Care</topic><topic>Anxiety-Depression</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Correlation coefficients</topic><topic>Edmonton Symptom Assessment System</topic><topic>ESAS</topic><topic>Female</topic><topic>Humans</topic><topic>Korea</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - psychology</topic><topic>Pain Medicine</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevalence</topic><topic>Psychometrics - methods</topic><topic>Psychometrics - statistics & numerical data</topic><topic>Quality of Life</topic><topic>Reproducibility of Results</topic><topic>Republic of Korea - epidemiology</topic><topic>Responsiveness</topic><topic>Sensitivity and Specificity</topic><topic>Surveys and Questionnaires</topic><topic>Symptom Assessment - methods</topic><topic>Symptom Assessment - statistics & numerical data</topic><topic>Symptoms</topic><topic>Test-Retest reliability</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kwon, Jung Hye, MD, PhD</creatorcontrib><creatorcontrib>Nam, Seung-Hyun, MD</creatorcontrib><creatorcontrib>Koh, Sujin, MD, PhD</creatorcontrib><creatorcontrib>Hong, Young Seon, MD, PhD</creatorcontrib><creatorcontrib>Lee, Kyung Hee, MD, PhD</creatorcontrib><creatorcontrib>Shin, Sang-Won, MD, PhD</creatorcontrib><creatorcontrib>Hui, David, MD, MSc, FRCPC</creatorcontrib><creatorcontrib>Park, Kyun Woo, MD</creatorcontrib><creatorcontrib>Yoon, So Young, MD, PhD</creatorcontrib><creatorcontrib>Won, Ji Yun, RN</creatorcontrib><creatorcontrib>Chisholm, Gary, MS</creatorcontrib><creatorcontrib>Bruera, Eduardo, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><jtitle>Journal of pain and symptom management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kwon, Jung Hye, MD, PhD</au><au>Nam, Seung-Hyun, MD</au><au>Koh, Sujin, MD, PhD</au><au>Hong, Young Seon, MD, PhD</au><au>Lee, Kyung Hee, MD, PhD</au><au>Shin, Sang-Won, MD, PhD</au><au>Hui, David, MD, MSc, FRCPC</au><au>Park, Kyun Woo, MD</au><au>Yoon, So Young, MD, PhD</au><au>Won, Ji Yun, RN</au><au>Chisholm, Gary, MS</au><au>Bruera, Eduardo, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer</atitle><jtitle>Journal of pain and symptom management</jtitle><addtitle>J Pain Symptom Manage</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>46</volume><issue>6</issue><spage>947</spage><epage>956</epage><pages>947-956</pages><issn>0885-3924</issn><eissn>1873-6513</eissn><coden>JSPME2</coden><abstract>Abstract Context The Edmonton Symptom Assessment System (ESAS) is a brief, widely adopted, multidimensional questionnaire to evaluate patient-reported symptoms. Objectives To develop a Korean version of the ESAS (K-ESAS) and to perform a psychometric analysis in Korean patients with advanced cancer. Methods We tested the K-ESAS in two pilot studies with 15 patients each. We assessed internal consistency, test-retest reliability, and concurrent validity in 163 Korean patients, who completed the K-ESAS along with the Korean versions of the M. D. Anderson Symptom Inventory (K-MDASI) and the Hospital Anxiety and Depression Scale (K-HADS) twice. A total of 38 patients completed the questionnaires again seven days later to assess responsiveness. Results The K-ESAS scores had good internal consistency, with a Cronbach's alpha coefficient of 0.88, indicating that no questions had undue influence on the score. Pearson correlation coefficients for K-ESAS symptom scores between baseline and after two to four hours ranged from 0.72 (95% CI 0.64–0.79) to 0.87 (95% CI 0.82–0.90), indicating strong test-retest reliability. For concurrent validity, Pearson correlation coefficients between K-ESAS symptom scores and corresponding K-MDASI symptom scores ranged from 0.70 (95% CI 0.62–0.77) to 0.83 (95% CI 0.77–0.87), indicating good concurrent validity. For the K-HADS, concurrent validity was good for anxiety ( r = 0.73, 95% CI 0.65–0.79) but moderate for depression ( r = 0.4, 95% CI 0.26–0.52). For responsiveness, changes in K-ESAS scores after seven days were moderately correlated with changes in K-MDASI scores but weakly correlated with changes in K-HADS scores. Conclusion The K-ESAS is a valid and reliable tool for measuring multidimensional symptoms in Korean patients with cancer.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>23628516</pmid><doi>10.1016/j.jpainsymman.2013.01.012</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3924 |
ispartof | Journal of pain and symptom management, 2013-12, Vol.46 (6), p.947-956 |
issn | 0885-3924 1873-6513 |
language | eng |
recordid | cdi_proquest_miscellaneous_1550986325 |
source | Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Freedom Collection |
subjects | Advanced cancer Aged Anesthesia & Perioperative Care Anxiety-Depression Biological and medical sciences Cancer Correlation coefficients Edmonton Symptom Assessment System ESAS Female Humans Korea Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasms - diagnosis Neoplasms - epidemiology Neoplasms - psychology Pain Medicine Pharmacology. Drug treatments Prevalence Psychometrics - methods Psychometrics - statistics & numerical data Quality of Life Reproducibility of Results Republic of Korea - epidemiology Responsiveness Sensitivity and Specificity Surveys and Questionnaires Symptom Assessment - methods Symptom Assessment - statistics & numerical data Symptoms Test-Retest reliability Tumors |
title | Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A55%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20the%20Edmonton%20Symptom%20Assessment%20System%20in%20Korean%20Patients%20With%20Cancer&rft.jtitle=Journal%20of%20pain%20and%20symptom%20management&rft.au=Kwon,%20Jung%20Hye,%20MD,%20PhD&rft.date=2013-12-01&rft.volume=46&rft.issue=6&rft.spage=947&rft.epage=956&rft.pages=947-956&rft.issn=0885-3924&rft.eissn=1873-6513&rft.coden=JSPME2&rft_id=info:doi/10.1016/j.jpainsymman.2013.01.012&rft_dat=%3Cproquest_cross%3E1464891632%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c546t-4335d8ad69b1853332dc658925e361780ae5ced598e2a6d0424d7ee94130e25b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1464891632&rft_id=info:pmid/23628516&rfr_iscdi=true |